Systematic Overview of Warfarin and Its Drug and Food Interactions
Top Cited Papers
Open Access
- 23 May 2005
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 165 (10), 1095-1106
- https://doi.org/10.1001/archinte.165.10.1095
Abstract
Warfarin is the most commonly used oral anticoagulant in North America and has established efficacy for the prevention of thromboembolic events in patients with chronic atrial fibrillation, prosthetic heart valves, venous thromboembolism, and coronary artery disease.1-4 The drug is a racemic mixture of 2 optically active isomers, though the S-enantiomer is approximately 5 times more potent than the R-enantiomer. Warfarin exerts its effect by lowering the amount of active vitamin K available for the activation of clotting factors II, VII, IX, and X.5 Both effectiveness and safety (primarily risk of bleeding) are related to blood international normalized ratio (INR) values. Monitoring of INR and dose adjustments of warfarin are frequently required, influenced by changes in concomitant medications, diet, alcohol consumption, acute illness, liver disease, and unknown factors.5Keywords
This publication has 93 references indexed in Scilit:
- The effect of anastrozole on the single‐dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteersBritish Journal of Clinical Pharmacology, 2001
- Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarinBritish Journal of Clinical Pharmacology, 1997
- Effect of vitamin E on the anticoagulant response to warfarinThe American Journal of Cardiology, 1996
- Losartan Does Not Affect the Pharmacokinetics and Pharmacodynamics of WarfarinThe Journal of Clinical Pharmacology, 1995
- Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarin [see comments]British Journal of Clinical Pharmacology, 1995
- Stereoselective Interaction of Omeprazole with Warfarin in Healthy MenTherapeutic Drug Monitoring, 1989
- Stereoselective interaction of sulfinpyrazone with racemic warfarin and its separated enantiomorphs in man.Circulation, 1982
- The Effect of Bumetanide on the Serum Disappearance of Warfarin SodiumThe Journal of Clinical Pharmacology, 1981
- Stereoselective Interaction of Trimethoprim-Sulfamethoxazole with the Separated Enantiomorphs of Racemic Warfarin in ManNew England Journal of Medicine, 1980
- The effect of fluoxetine on warfarin metabolism in the rat and manLife Sciences, 1978